Kolexia
Assenat Eric Gastro-entérologie
Assenat Eric
Gastro-entérologie
Icm Montpellier
Montpellier, France
304 Activités
87 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome hépatocellulaire Tumeurs du foie Métastase tumorale Adénocarcinome Tumeurs du pancréas Tumeurs colorectales Tumeurs des voies biliaires Carcinome du canal pancréatique

Collaborateurs

Voir plus
Ychou Marc
Ychou Marc
Icm Montpellier, Montpellier, France
Blanc Jean-Frederic
Blanc Jean-Frederic
Hôpital Saint-André, Bordeaux, France
Mazard Thibault
Mazard Thibault
Icm Montpellier, Montpellier, France
Guiu Boris
Guiu Boris
Hôpital Saint-Éloi, Montpellier, France

Industries

Voir plus
Ipsen
27 collaboration(s)
Dernière en 2023
AstraZeneca
24 collaboration(s)
Dernière en 2023
Bayer
21 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
13 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma: A Randomized, Multi-center Phase III Study of Nivolumab Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (CheckMate 459: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 459)
Essai Clinique (BMS)   15 mars 2024
Effectiveness of endoscopic ultrasound (EUS)-guided choledochoduodenostomy vs. EUS-guided gallbladder drainage for jaundice in patients with malignant distal biliary obstruction after failed endoscopic retrograde cholangiopancreatography: Retrospective, multicenter study (GALLBLADEUS Study).
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society   21 février 2024
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma
JHEP reports : innovation in hepatology   28 janvier 2024
FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis.
EMBO molecular medicine   16 janvier 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   16 janvier 2024
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   11 janvier 2024
Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCC: RATIONALE-301: A Randomized, Open-label, Multicenter Phase 3 Study to Compare the Efficacy and Safety of BGB-A317 Versus Sorafenib as First-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma
Essai Clinique (BeiGene)   08 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024